Neurogene
Likely to Engage tag.Highly Engaged Employees

Blood & Organ Banks · New York, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

535 W 24th St Fl 5, New York, New York, ...

Phone Number

(855) 508-3568

Revenue

-

Stock Symbol

NGNE

Industry

Blood & Organ Banks Business Services Healthcare Services Research & Development

About Neurogene

Neurogene Inc. is dedicated to developing life-changing genetic medicines aimed at treating devastating neurological diseases, particularly focusing on rare conditions like Rett syndrome. The company employs a proprietary gene therapy platform to address the high unmet needs of patients and their families affected by these disorders. Neurogene emphasizes collaboration with patient communities to ensure their perspectives are integrated into the research and development process. Their mission is to transform the treatment landscape for neurological diseases through innovative scientific approaches and robust execution.Explore more
Neurogene's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: NGNEShow more

Neurogene Org Chart

RM
United States flag for contact location.

Founder & Chief Executive Officer

PhoneEmail
CM
United States flag for contact location.

Vice President, Corporate Affairs & To The Ch...

PhoneEmail
EA
United States flag for contact location.

Chief Medical Officer

PhoneEmail
Julie Jordan, Chief Medical Officer at Neurogene
United States flag for contact location.

Chief Medical Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
JD
United States flag for contact location.

Senior VP, Finance

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Neurogene

Compare insights from companies similar to Neurogene, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Neurogene

51-200
Public
$383.5M
2018
RM
Rachel McMinnFounder & CEO
$440.5M
201-500
Public
-
2015
Hiroshi Kasamoto, President & General Manager (Japan) at Krystal Biotech
Hiroshi KasamotoPresident & General Manager (Japan)
$66.4M
51-200
Private
$25M
2008
Timothy Largen, Chief Operating Officer at Applied Stemcell
Timothy LargenChief Operating Officer
$54.7M
51-200
Private
$566.3M
2014
CS
Carol SuslaVice President, Quality
$42.3M
51-200
Private
-
2016
Seth Ettenberg, President & Chief Executive Officer at BlueRock Therapeutics
Seth EttenbergPresident & CEO
$25.4M
11-50
Private
<$5M
2007
IT
Irene TennantRegulatory Affairs Vice President, Clinical Development
<$5M
51-200
Private
$147.5M
2018
KP
Ken PrenticeSenior VP & Head of Process Development & Manufacturing
Illustration of an envelope

Neurogene Tech Stack

A closer look at the technologies used by Neurogene

Top Blood & Organ Banks Companies

Frequently Asked Questions Regarding Neurogene

What is Neurogene's stock symbol?
Neurogene's stock symbol is NGNE
What is Neurogene's official website?
Neurogene's official website is www.neurogene.com
What is Neurogene's SIC code?
Neurogene's SIC: 28,283
What is Neurogene's NAICS code?
Neurogene's NAICS: 32,325
How many employees does Neurogene have?
Neurogene has 51-200 employees
What industry does Neurogene belong to?
Neurogene is in the industry of: Blood & Organ Banks, Business Services, Healthcare Services
What is Neurogene competition?
Neurogene top competitors include: BlueRock Therapeutics, Applied Stemcell, Shape Therapeutics, Poseida Therapeutics
What companies has Neurogene acquired?
Neurogene has acquired the companies: Aquinox Pharmaceuticals, Neoleukin Therapeutics
What technology does Neurogene use?
Some of the popular technologies that Neurogene uses are: WordPress.org, PHP, Cloudflare Website Optimization, DoubleClick
Who is the CFO of Neurogene?
Neurogene's CFO is Cara Mayfield
How do I contact Neurogene?
Neurogene contact info: Phone number: (855) 508-3568 Website: www.neurogene.com
What does Neurogene do?

Neurogene Inc. is dedicated to developing life-changing genetic medicines aimed at treating devastating neurological diseases, particularly focusing on rare conditions like Rett syndrome. The company employs a proprietary gene therapy platform to address the high unmet needs of patients and their families affected by these disorders. Neurogene emph... asizes collaboration with patient communities to ensure their perspectives are integrated into the research and development process. Their mission is to transform the treatment landscape for neurological diseases through innovative scientific approaches and robust execution.Read More

What are Neurogene social media links?
Neurogene Linkedin page Neurogene Twitter page Neurogene Facebook page
Who invested in Neurogene?
Neurogene has 7 investors including Casdin Capital , LLC, Avidity Partners LLC, BlackRock and Janus Henderson Group plc.
Is Neurogene a public company?
Yes, Neurogene is a public company and is traded under the symbol NGNE
See more information about Neurogene

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.